These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35908005)

  • 1. Over-Prescription of the Imidazoline Receptor Agonists: Evidence for Restriction of the Therapeutic Indication.
    Jankūnas R; Rinkūnienė D; Stakišaitis D
    Ther Innov Regul Sci; 2022 Sep; 56(5):859-866. PubMed ID: 35908005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta-analysis.
    Érszegi A; Viola R; Bahar MA; Tóth B; Fejes I; Vágvölgyi A; Csupor D
    Pharmacol Res Perspect; 2024 Jun; 12(3):e1215. PubMed ID: 38807350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study.
    Kasciuškevičiūtė S; Gumbrevičius G; Vendzelytė A; Ščiupokas A; Petrikonis K; Kaduševičius E
    Medicina (Kaunas); 2018 May; 54(2):. PubMed ID: 30344261
    [No Abstract]   [Full Text] [Related]  

  • 4. Infant mortality gap in the Baltic region - Latvia, Estonia, and Lithuania - in relation to macroeconomic factors in 1996-2010.
    Ebela I; Zile I; Ebela DR; Rozenfelde IR
    Medicina (Kaunas); 2013; 49(10):453-61. PubMed ID: 24709788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally acting imidazoline I1-receptor agonists: do they have a place in the management of hypertension?
    van Zwieten PA
    Am J Cardiovasc Drugs; 2001; 1(5):321-6. PubMed ID: 14728014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology in Estonia, Latvia and Lithuania: From historical roots to nowadays achievements.
    Jansone B; Kuum M; Maciulaitis R
    Pharmacol Res; 2016 Nov; 113(Pt B):723-730. PubMed ID: 27168226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of psychotropic medication use in the Baltic countries.
    Harro J; Aadamsoo K; Rootslane L; Laius O; O'Leary A; Adomaitiene V; Kupca B; Lehtmets A; Navickas A; Rancans E; Taube M; Terauds E; Pops K
    Nord J Psychiatry; 2020 May; 74(4):301-306. PubMed ID: 31889460
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: role of imidazoline I(1) receptors.
    Li F; Wu N; Su RB; Liu Y; Lu XQ; Li J
    Eur J Pharmacol; 2009 Jun; 612(1-3):1-8. PubMed ID: 19356733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the Dyslipidemia International Study (DYSIS).
    Viigimaa M; Erglis A; Latkovskis G; Mäeots E; Petrulionienė Ž; Šlapikas R; Gocentiene A; Bramlage P; Brudi P
    Medicina (Kaunas); 2014; 50(1):44-53. PubMed ID: 25060204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy.
    Stakišaitis D; Zamarytė-Sakavičienė K; Lesauskaitė V; Jankūnas RJ
    Ther Innov Regul Sci; 2019 Jul; 53(4):549-553. PubMed ID: 30200777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption in the Baltic Republics.
    McKee M; Pomerleau J; Robertson A; Pudule I; Grinberga D; Kadziauskiene K; Abaravicius A; Vaask S
    J Epidemiol Community Health; 2000 May; 54(5):361-6. PubMed ID: 10814657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania.
    Arbyn M; Antoine J; Valerianova Z; Mägi M; Stengrevics A; Smailyte G; Suteu O; Micheli A
    Tumori; 2010; 96(4):517-23. PubMed ID: 20968129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine.
    Van Zwieten PA; Peters SL
    Ann N Y Acad Sci; 1999 Jun; 881():420-9. PubMed ID: 10415946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific Publications in Dentistry in Lithuania, Latvia, and Estonia Between 1996 and 2018: A Bibliometric Analysis.
    Poskevicius L; De la Flor-Martínez M; Galindo-Moreno P; Juodzbalys G
    Med Sci Monit; 2019 Jun; 25():4414-4422. PubMed ID: 31197127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of selective imidazoline receptor agonists in modern hypertension management: an international real-world survey (STRAIGHT).
    Schlaich MP; Almahmeed W; Arnaout S; Prabhakaran D; Zhernakova J; Zvartau N; Schutte AE
    Curr Med Res Opin; 2020 Dec; 36(12):1939-1945. PubMed ID: 33047993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
    Ernsberger P; Friedman JE; Koletsky RJ
    J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.